King & Spalding, LLP v. United States Department of Health & Human Services

270 F. Supp. 3d 46
District Court, District of Columbia·Decided September 6, 2017·No. Civil Action No. 2016-1616·Published·Cited by 2 cases

Opinion

MEMORANDUM OPINION AND ORDER

Amit P. Mehta, United States District Judge

Before the court are the parties’ cross-motions for summary judgment in this action brought under the Freedom of Information Act (“FOIA”). See Defs.’ Mot. for Summ. J., ECF No. 20 [hereinafter Defs.’ Mot.]; Pl.’s Cross-Mot. for Summ. J., ECF No. 21 [hereinafter Pl.’s Crossr-Mot.]. The court has reviewed the parties’ briefs and accompanying materials and finds that this matter cannot be resolved on the present record; As discussed further below, Defendants’ reliance on FOIA Exemptions 7(C) and 7(D), see 5 U.S.C. § 552(b)(7)(C), (D), to withhold certain law enforcement records raises a threshold . question: Whether the source of those records is, an entity or an individual. Because Defendants’ affiants do not answer that question, the court cannot assess whether the Government’s withholdings are appropriate at this time. As a result, the court denies the parties’ Motions without prejudice and will allow Defendants to submit additional information .concerning the identity of the confidential source.

Plaintiff King & Spalding LLP (“Plaintiff’) filed three separate FOIA requests with Defendants U.S. Department of Health and Human Services and U.S. Department of Justice (“Defendants”) for documents concerning Plaintiffs client, Abiomed, Inc., that Defendants received from an anonymous source between January 1, 2012, and October 31, 2012. See Defs.’ Mot. at 3-8 [hereinafter Defs.’ Stmt, of Material Facts], ¶¶2, 10, 14; Pl.’s Cross-Mot. at 3-8 [hereinafter Pl.’s Stmt, of Material Facts], ¶¶2, 10, 14. 1 Plaintiff suspects that Defendants’ receipt of that information led to a federal criminal investigation into whether Abiomed was engaged in off-labeling marketing practices, i.e., promoting drugs for uses outside of those approved by the U.S. Food and Drug Administration. See PL’s Cross-Mot. at 11-46 [hereinafter PL’s Mem.], at 17. Plaintiff believes one of Abiomed’s competitors in the pharmaceutical industry, Ma-quet, may be the Government’s anonymous source. Id. at 32-33.

In response to Plaintiffs FOIA requests, Defendants produced some documents, but withheld others. See Defs.’ Stmt, of Material Facts ¶¶ 6, 11, 15-16; PL’s Stmt, of Material Facts ¶¶ 6,11,15-16. Specifically, Defendants withheld, in full, 67 pages containing responsive information that generally falls into two categories: (1) “the names of government personnel, the name of an attorney representing [the] unnamed source and the names of third parties who appear[ ] in. the documents [provided by the unnamed source]” under Exemption 7(C), and (2) certain material that could reveal the identity of the .Government’s unnamed source under Exemption 7(D). See Defs.’ Reply in Supp. of Defs.’ Mot, ECF No. 25 [hereinafter Defs.’ Reply], at 13, 17-19; Defs.’ Stmt, of Material Facts ¶¶ 15-16; PL’s Stmt, of Material Facts ¶¶ 15-16; Defs.’ Mot. at 9-28 [hereinafter Defs.’ Mem.], at 22-27; PL’s Mem. at 17. The parties dispute whether FOIA Exemptions 7(C) and 7(D) can be properly used to withhold—either in full or in *48 part—those two categories of materials. 2 See Defs.’ Mem. at 23-27; Pl.’s Mem. at 24-38.

The court cannot, however, resolve that dispute on the present record. Exemption 7(C) protects from, disclosure “records or information compiled for law enforcement purposes, but only to the extent that the production of such law enforcement records or information ... could reasonably be expected to constitute an unwarranted invasion of personal privacy.” 5 U.S.C. § 552(b)(7)(C). To determine whether the release of information would constitute an “unwarranted invasion of privacy,” the court must balance “the privacy interests that would be compromised by disclosure against the public interest in release of the requested information.” Davis v. U.S. Dep’t of Justice, 968 F.2d 1276, 1281 (D.C. Cir. 1992). Exemption 7(D), by contrast, protects from disclosure “records or information compiled for law enforcement purposes ... [that] could reasonably be expected to disclose the identity of a confidential source ... and, in the case of [records] or information compiled by a criminal law enforcement authority ... information furnished by [the] source.” 5 U.S.C. § 552(b)(7)(D). “Unlike Exemption 7(C), Exemption 7(D) does not require balancing,” but does require the Government to “present probative evidence that the source” provided information to the Government under either an express or implied assurance that its identity would remain confidential. Citizens for Responsibility & Ethics in Wash. v. U.S. Dep’t of Justice, 746 F.3d 1082, 1101 (D.C. Cir. 2014) (internal quotation marks omitted).

Free access — add to your briefcase to read the full text and ask questions with AI

King & Spalding, LLP v. United States Department of Health & Human Services, 270 F. Supp. 3d 46 (D.D.C. 2017).

270 F. Supp. 3d 46 (King & Spalding, LLP v. United States Department of Health & Human Services) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related